Amino Collective invests in radical, free-thinking founders building life-changing solutions at the intersection of health, biology, and AI. They focus on early-stage companies with a European origin and global scaling potential, leveraging AI, precision medicine, and innovative scientific approaches to address unmet medical needs and transform industries like drug discovery, diagnostics, and healthcare delivery.
Preferred startup development maturity for initial funding deployment.
Early-stage ventures in health, bio, and AI-driven scientific innovation with a European focus and global scaling ambition.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...